6875.TWO · PBI
Taiwan · RS rating 1 · As of 2026-10-08
| Price | 27.00 TWD |
|---|---|
| 1-day change | -0.2% |
| RS rating (overall / 1M / 3M / 12M) | 1 / 2 / 3 / 6 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 25 / 12 / 27 |
| Industry group (rank) | Medical-Biomed/Biotech (53) |
| EPS growth Q/Q | -6.8% |
| Sales growth Q/Q | -100.0% |
| Distance from 52-week high | +55.6% |
| Market cap (USD) | $121.0M |